Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRNE | BMY | AMGN | REGN | GILD |
| Company | Sorrento Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0200 | 44.68 | 265.72 | 881.72 | 65.50 |
| High | 0.0200 | 45.37 | 271.68 | 887.48 | 66.35 |
| Low | 0.0135 | 44.34 | 265.72 | 875.23 | 64.63 |
| Last | 0.0137 | 45.13 | 270.95 | 883.34 | 65.56 |
| Change | -0.0063 | +0.43 | +1.57 | -7.34 | +0.29 |
| % Change | -31.50% | +0.96% | +0.58% | -0.82% | +0.44% |
| Volume | 49,916 | 11,912,095 | 1,062,488 | 318,874 | 9,088,888 |
| 20-Day Average Volume | 261,876 | 12,707,475 | 2,083,976 | 446,670 | 6,879,647 |
| Previous Close | 0.0200 | 44.70 | 269.38 | 890.68 | 65.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0205 | 49.49 | 270.04 | 918.57 | 68.31 |
| 20-Day Raw Stochastic | 16.06% | 9.35% | 44.94% | 8.90% | 13.10% |
| 20-Day Relative Strength | 45.28% | 31.37% | 46.69% | 33.20% | 31.13% |
| Weighted Alpha | -94.74 | -33.56 | +10.09 | +9.90 | -22.94 |
| Today's Opinion | 88% Sell | 88% Sell | 56% Sell | 8% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 88% Sell | 72% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 8% Buy | 40% Buy | 80% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -31.50% since 04/19/24 | -7.49% since 04/19/24 | +0.81% since 04/19/24 | -1.47% since 04/19/24 | -1.51% since 04/19/24 |
| Low | 0.0001 on 04/24/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 875.22 on 04/26/24 | 64.63 on 04/26/24 |
| High | 0.0220 on 04/22/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 915.70 on 04/24/24 | 67.90 on 04/25/24 |
| 1-Month | |||||
| %Chg | +52.22% since 03/26/24 | -13.86% since 03/26/24 | -3.78% since 03/26/24 | -8.29% since 03/26/24 | -9.19% since 03/26/24 |
| Low | 0.0001 on 04/24/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 64.63 on 04/26/24 |
| High | 0.0848 on 04/15/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 976.75 on 03/27/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -51.07% since 01/26/24 | -8.92% since 01/26/24 | -13.04% since 01/26/24 | -6.00% since 01/26/24 | -17.31% since 01/26/24 |
| Low | 0.0001 on 04/24/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 64.63 on 04/26/24 |
| High | 0.0995 on 02/23/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 80.00 on 01/29/24 |
| 6-Month | |||||
| %Chg | -83.79% since 10/26/23 | -14.55% since 10/26/23 | +0.52% since 10/26/23 | +11.57% since 10/26/23 | -16.24% since 10/26/23 |
| Low | 0.0001 on 04/24/24 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 769.19 on 10/27/23 | 64.63 on 04/26/24 |
| High | 0.2495 on 12/22/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,026 | 90,596,128 | 144,488,960 | 97,762,816 | 81,266,176 |
| Shares Outstanding, K | 551,281 | 2,026,759 | 536,376 | 109,762 | 1,245,077 |
| Annual Sales | 62,840,000 | 45,006,000,000 | 28,190,000,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -572,840,000 | 8,025,000,000 | 6,717,000,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 15,030,000 | 11,477,000,000 | 8,196,000,000 | 3,434,300,000 | 7,114,000,000 |
| Last Quarter Net Income | -95,210,000 | 1,762,000,000 | 767,000,000 | 1,159,600,000 | 1,429,000,000 |
| 60-Month Beta | 2.25 | 0.39 | 0.58 | 0.11 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 08/11/23 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | 11.86 on 02/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 24.12 | 9.98 |